This paper will give an overview of my 40-year career, spanning both industry and academe, and two continents. The foundation of my North American career was laid in the Kennedy lab at the University of Akron in 1980 and 1986-88 before moving to Canada. During my industrial years in Canada I solved long-standing (10 year) major manufacturing problems and developed on-line and off-line process control tools that are still in operation. I also developed new technologies (bimodal butyl, one-step halobutyl, branched butyl, liquid carbon dioxide process) that resulted in patents. After transferring to academe I continued the development of new polyisobutylene-based materials. I have held the Bayer (LANXESS) Industrial Research Chair for 12 years (8 years in Canada and 4 years in Akron), working closely with the rubber industry. My most important accomplishments include developing advanced elastomers and thermoplastic elastomers for healthcare, enzyme-catalyzed polymer functionalization, a "green" synthesis of disulfide polymers and gels, and research into natural rubber biosynthesis. Poly(styrene-isobutylenepolystyrene) is used on an FDA-approved drug-eluting stent, implanted in over six million patients, saving lives. The recently patented poly(alloocimene-isobutylene-alloocimene) is also a potential biomaterial, and also a potential halogen-free halobutyl rubber. I will also discuss my adventure of a field experiment at a Brazilian Hevea plantation to verify our laboratory discovery that the rubber content of Hevea latex can be increased by 20-50% using a special method of tapping. My goal now is creating safer breast implants with cancer-fighting and healing properties, in collaboration with the Cleveland Clinic. I am proud that the Rubber World trade journal listed me among the 125 inventors that influenced rubber technology in a profound way.
